Day

September 26, 2019
Kineta – Developing Novel Immunotherapies That Transform Patients’ Lives Kineta, Inc. is a clinical stage biotechnology company committed to developing disruptive life science technologies that address unmet patient needs. The company’s management team leverages expertise in immunology, drug development and corporate finance to advance a focused pipeline of investigational drugs in oncology, neuroscience and virology....
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases